Abstract
As rates of global obesity and diabetes increase, diabetic retinopathy continues to grow as a frequent cause of visual impairment. Despite tremendous recent strides in therapy, a significant fraction of patients remain poorly responsive to modern interventions. Adjunctive therapy in such settings could be widely beneficial. A growing body of evidence suggests that weight reduction strategies for obesity-related diabetes have the potential to serve as important supplements to modern ophthalmic care for preservation of vision.
Original language | English |
---|---|
Pages (from-to) | 42-48 |
Number of pages | 7 |
Journal | Missouri Medicine |
Volume | 119 |
Issue number | 1 |
State | Published - Jan 1 2022 |